How Is MGUS Monitored?

https://vimeo.com/779453510 Myeloma expert Dr. Irene Ghobrial discusses how patients with monoclonal gammopathy of undetermined significance (MGUS) are monitored over time and shares an update on research being conducted to learn…

What Should Patients Know About Myeloma Testing?

https://vimeo.com/779453701 Testing following a myeloma diagnosis, or relapse, can impact care and treatment decisions. Drs. Betsy O’Donnell and Omar Nadeem provide an overview of essential myeloma testing, how the test…

Understanding MGUS & Smoldering Myeloma: What’s the Difference?

https://vimeo.com/779453854 Myeloma expert Dr. Irene Ghobrial explains the difference between the precursor conditions, MGUS (monocloncal gammopathy of undetermined significance) and smoldering myeloma, including how these conditions are detected. Dr. Irene…

Advances in Myeloma Molecular Testing

What is molecular testing, and how does it impact myeloma care? Dr. Abdullah Khan from the Ohio State University Comprehensive Cancer Center – The James discusses the specific markers found…

How Do Test Results Impact Myeloma Treatment Options?

https://vimeo.com/755523666 Myeloma expert Dr. Melissa Alsina reviews the test results that are taken into consideration when choosing a treatment approach for patients. Dr. Melissa Alsina is an associate professor of…

How Should MGUS Be Monitored Over Time?

https://vimeo.com/652660490 Myeloma expert, Dr. Saad Usmani, discusses the diagnosis of monoclonal gammopathy of undetermined significance (MGUS) and how patients are monitored, including key lab values that should be followed. Dr….

How Is Myeloma Treatment Effectiveness Monitored?

https://vimeo.com/652660589 Once you begin myeloma therapy, how do you know if it’s working? Dr. Saad Usmani, a myeloma expert, shares how patients are monitored via various tests and reviews how…

Share On:

Facebook
Twitter
LinkedIn